Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052990
Filing Date
2020-11-10
Accepted
2020-11-10 16:22:49
Documents
84
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q plrx-10q_20200930.htm 10-Q 3257135
2 EX-10.1 plrx-ex101_224.htm EX-10.1 21799
3 EX-31.1 plrx-ex311_6.htm EX-31.1 15688
4 EX-31.2 plrx-ex312_8.htm EX-31.2 15614
5 EX-32.1 plrx-ex321_9.htm EX-32.1 8644
6 GRAPHIC g435zjrvnrb4000001.jpg GRAPHIC 2746
  Complete submission text file 0001564590-20-052990.txt   10479723

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT plrx-20200930.xml EX-101.INS 2057973
8 XBRL TAXONOMY EXTENSION SCHEMA plrx-20200930.xsd EX-101.SCH 71468
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plrx-20200930_cal.xml EX-101.CAL 41527
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plrx-20200930_def.xml EX-101.DEF 335515
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE plrx-20200930_lab.xml EX-101.LAB 535770
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plrx-20200930_pre.xml EX-101.PRE 476660
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 201301462
SIC: 2834 Pharmaceutical Preparations